ImpactOS
See an example

Pfizer Inc

Companies and groups · United States

In these lists: Medicines

Declared lobbying cost
€1,250,000 – €1,499,999 Financial year 01/2025-12/2025
Commission meetings
5
Full-time staff on EU lobbying
1.5
European Parliament access passes
2
Registered since
18 Dec 2008
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Budget, Business and industry, Competition, Digital economy and society, Economy, finance and the euro, Environment, External relations, Foreign affairs and security policy, Institutional affairs, Public health, Research and innovation, Single market, Taxation, Trade

Medicines and food topics they name

EU medicines law, Critical medicines, Orphan and paediatric medicine incentives, Health technology assessment, Vaccines

EU laws and policies they declare following1
  • Revision of the EU pharmaceutical legislation, EU Biotech Act, EU Critical Medicines Act, Urban Wastewater Treatment Directive, Paediatric & Orphan Medicinal Products, Vaccination policy, Health Tech…

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Cabinet

    Stéphane Séjourné

    Universal PFAS restriction under REACH

    Published record
  2. With the Commissioner

    Olivér Várhelyi

    Life Sciences Roundtable

    Published record
  3. With the Cabinet

    Published record
  4. With the Commissioner

    Stéphane Séjourné

    - Marché intérieur - Compétitivité - Sécurité économique - Simplification - Relation USA / Europe

    Published record
  5. With the Cabinet

    Stéphane Séjourné

    - Marché intérieur - Compétitivité - Sécurité économique - Simplification - Relation USA / Europe

    Published record

Official entries

Name in the register: Pfizer Inc.

Checked against sources on 11 Nov 2026